• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Themis Biosyn Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Themis
  • BSE Code : 216.0
  • ISIN : INE942C01045
373.35 -18 (-4.62%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    364.70

  • Today’s High

    405.00

  • Open

    393.30

  • Perv Close

    391.45

  • 52W Low

    208.00

  • 52W High

    405.00

Key Indicators

  • P/E(TTM)

    90.92

  • Mar.Cap (₹Cr.)

    4,068.22

  • Div & Yield %

    0.18

  • Book Value(₹)

    22.80

  • Debt-Equity Ratio

    -4.62

  • AGM Date

    01-Aug-2025

  • EPS

    4.09

  • P/E Ratio

    90.92

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    4,068.22

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.90

  • BV (₹)

    22.80

  • Sales( ₹ in Cr.)

    150.80

  • NP (in Cr.)

    48.77

  • NP Var(%)

    -18.0

  • Div%

    67.0

  • CPS (₹)

    5.00

  • EPS (₹)

    4.50

  • Traded Value (₹ in Lakhs)

    4,051.87

  • 52 Week High

    405.00

  • 52 Week Low

    208.00

  • Price BSE

    372.0

  • Price NSE

    373.00

  • Market Capital( in Cr.)

    4,051.87

  • P/C Ratio

    74.90

  • P/E Ratio

    83.10

  • Price Vs.BV

    4.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 169.82 148.39 114.85 90.56 85.12 41.05
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 169.82 148.39 114.85 90.56 85.12 41.05
Other Income 4.38 6.59 4.05 3.27 1.70 2.21
Stock Adjustments -11.01 3.24 5.13 0.38 4.11 0.00
Total Income 163.19 158.22 124.03 94.21 90.93 43.26
EXPENDITURE :            
Raw Materials 25.67 29.73 21.75 15.75 15.44 1.30
Power and Fuel Cost 26.53 26.41 21.73 16.57 22.86 20.20
Employee Cost 10.21 7.75 7.08 7.11 6.43 5.17
Other Manufacturing Expenses 8.54 6.80 7.91 8.79 10.53 5.29
Selling and Administration Expenses 8.51 6.66 2.31 1.86 1.64 1.39
Miscellaneous Expenses 0.61 0.64 1.15 0.53 0.49 0.35
Employee Benefit Expenses 10.21 7.75 7.08 7.11 6.43 5.17
Less: Preoperative Expenditure -0.01 0.00 0.00 0.00 0.00 0.00
Total Expenses 80.09 77.99 61.94 50.61 57.39 33.68
Operating Profit 83.10 80.22 62.10 43.59 33.54 9.58
Interest 0.23 0.18 0.83 0.98 0.92 0.16
Gross Profit 82.87 80.04 61.27 42.61 32.62 9.42
Depreciation 3.54 2.58 2.23 1.73 1.36 1.22
Profit Before Tax 79.33 77.46 59.04 40.88 31.26 8.20
Current Tax 19.80 19.24 15.34 10.58 7.64 0.87
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.38 0.26 0.07 0.13 -0.05 0.92
Reported Net Profit 59.16 57.97 43.62 30.18 23.67 6.41
Extraordinary Items 0.00 0.00 0.00 0.01 0.62 0.00
Adjusted Net Profit 59.16 57.97 43.62 30.17 23.05 6.41
Adjustment below Net Profit -0.03 0.06 -0.08 -0.03 0.00 0.00
P & L Balance brought forward 139.56 93.74 60.36 32.61 8.93 2.52
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 6.90 12.20 10.17 2.40 0.00 0.00
P & L Balance carried down 191.79 139.56 93.74 60.36 32.61 8.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 108.00 220.00 0.00 33.00 0.00
Dividend Per Share(Rs) 5.00 5.40 11.00 0.00 1.65 0.00
Earnings Per Share-Unit Curr 8.14 39.90 30.03 20.77 16.30 4.41
Earnings Per Share(Adj)-Unit Curr 5.43 5.32 4.00 2.77 2.17 0.59
Book Value 27.72 102.66 71.11 48.14 29.04 12.75
Book Value(Adj)-Unit Curr 18.48 13.69 9.48 6.42 3.87 1.70

Shareholding Pattern

  • Promoter Group

    70.86%

  • Public Share Holding

    29.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 76,512,037 70.22 76,512,037 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 706,046 0.65 706,041 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 77,218,083 70.86 77,218,078 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 750 0.00 750 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 250 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,735,584 2.51 2,735,584 10
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,269,182 1.16 1,255,182 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 10,250 0.01 0 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,016,016 3.69 3,991,516 18
2] Non Institution
Bodies Corporate 2,587,512 2.37 2,560,512 151
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,414,922 1.30 1,274,922 778
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,413,043 1.30 1,413,043 445
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,549,188 3.26 3,549,188 11
Individuals holding nominal share capital up to Rs. 1 lakh 17,493,534 16.05 16,499,949 27,504
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,000 0.00 750 2
Others 250 0.00 0 1
Sub Total 27,731,166 25.45 26,570,081 28,919
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 108,965,265 100.00 107,779,675 28,945

Company Background

Gujarat Themis Biosyn LtdPharmaceuticals - Indian - Bulk Drugs

  • Gujarat Themis Biosyn Ltd
  • BSE Code : 216.0
  • ISIN : INE942C01045

  • Incorporation Year

    1981

  • Registered Office

    69/C GIDC Industrial Estate
    Valsad Dist, VAPI,
    Gujarat-396195

  • Telephone

    91-260-2430027

  • FAX

    91-260-2400639

  • Chairman

    Dinesh S Patel

  • Managing Director

    Sachin D Patel

  • Company Secretary

    RAHUL DWARAKA SONI

  • Auditor

    GMJ & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gujarat Themis Biosyn Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Novartis India 967.25 398.23 356.27 23.23 16.64
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10